Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026.
- Largest single sale: $1.3M (39,712 shares) of NewAmsterdam Pharma Co N.V. on Jan 20, 2026. Filing
- Last sale before this period: Jan 28, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | Chief Financial Officer | Dec 29, 2023 | Jan 22, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jan 21, 2026, NewAmsterdam Pharma Co N.V.: sold 39,784 shares for $1.3M, under a disclosed plan; 39,784 shares acquired by exercising options. 1 filing: 1
- Jan 20, 2026, NewAmsterdam Pharma Co N.V.: sold 60,216 shares for $1.9M, under a disclosed plan; 60,216 shares acquired by exercising options. 1 filing: 1
- Jan 7, 2026, NewAmsterdam Pharma Co N.V.: 25,500 shares granted. 1 filing: 1
- Jan 5, 2026, NewAmsterdam Pharma Co N.V.: sold 5,118 shares for $170K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.